Uncategorized
New Hire – Chris Roberts – Vice President of Strategic Initiatives
We are pleased to announce that Chris Roberts will be joining #teamgravity as our Vice President of Strategic Initiatives. In this role, Chris will report directly to Tony Remington, Co-Founder & CEO, and be responsible for compliantly increasing testing volumes through strategic programming and partnerships. He will administer and manage growth-focused projects in collaboration with…
Read MoreUK St. Claire and Gravity Diagnostics to Enhance Substance Use Disorder Recovery with Advanced Toxicology Diagnostic Services
Morehead, KY – [12/19/24] – UK St. Claire will contract with Gravity Diagnostics for comprehensive and compliant toxicology diagnostic services to patients. After a competitive and selective bidding process, Gravity Diagnostics was selected to work with UK St. Claire to further strengthen efforts to support substance use disorder (SUD) recovery across the region. UK St.…
Read MoreKentucky Biomarker Bill: The Right Test for the Right Treatment
Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) The right test for the right treatment. The Commonwealth of Kentucky enacted HB180 this year which mandates insurance coverage of biomarker testing. Kentucky joins 13 other states with legislation addressing this complex issue. Biomarkers can either be direct targets or closely associated indicators of a disease. …
Read MorePGx: Truth, Hope, and Hype
Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) Pharmacogenetics (PGx) is the practice of applying the knowledge of an individual’s genes to guide the best therapeutic options. Given the generality of this definition, there are numerous ways to implement PGx in practice. In this article, we’ll cover the basics of PGx, detailing what it is and…
Read MoreGravity Diagnostics Expands Testing Services to Include Xylazine Detection: A Crucial Advancement in Ensuring Public Safety
[[Covington, KY] – [9/20/23] – Gravity Diagnostics, a leading clinical toxicology laboratory, is announcing a significant expansion of their testing services. They are now offering comprehensive testing for Xylazine, a powerful sedative and muscle relaxant. This groundbreaking addition to their testing portfolio demonstrates their unwavering commitment to advancing public health and safety. Xylazine, originally…
Read MoreGravity Diagnostics Partners with Film Cincinnati to Provide COVID-19 Testing
Gravity Diagnostics Sponsors Blood Drive with Hoxworth Blood Center and the University of Cincinnati
COVINGTON, KY – Gravity Diagnostics partnered with the Hoxworth Blood Center, a division of the University of Cincinnati, to host a blood drive in Covington, Kentucky. On July 8th, 56 Gravity employees took time out of their busy schedules to donate blood. Of the employees, 26 were first-time donors, a reminder that these events spearhead…
Read MoreGravity Diagnostics Receives $20 Million Line of Credit from PNC Bank to Support COVID-19 Testing
COVINGTON, Ky., Jan. 12, 2021 /PRNewswire/ — Gravity Diagnostics has announced that PNC Bank has authorized a $20 million line of credit to the diagnostics laboratory to support investments in inventory, equipment, and operations to increase its capacity and capabilities. Gravity Diagnostics is a full-service CLIA laboratory licensed in all 50 states providing laboratory testing in the areas of COVID-19,…
Read More